Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag On October 1, 2025, Trump will impose 100% tariffs on imported branded drugs unless production begins in the U.S., citing national security.

flag On October 1, 2025, President Trump will impose a 100% tariff on imported branded and patented pharmaceuticals unless manufacturers have begun construction on U.S. facilities, defined as breaking ground or being under construction. flag The move, based on a national security probe under Section 232, aims to boost domestic production amid concerns over supply chain vulnerabilities. flag Exemptions may apply to some EU and Japanese firms under a prior agreement, but details remain unclear. flag The administration also launched a new Section 232 investigation into medical equipment and supplies. flag Uncertainty persists over eligibility, enforcement, and potential impacts on drug prices and availability, with industry leaders urging clarity and warning of possible disruptions.

17 Articles